To investigate the role of RAD21 in tumor immunity, we selected both murine ID8 ovarian cancer cells and mouse OVA-expressing B16 melanoma cells (B16-OVA), two well-established mouse synergic tumor models with a higher expression of Rad21 (Supplemental Figure 5A). This evidence concerns the gene RAD21 and neoplasm.